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Functional Expression of Heme Oxygenase-1 in
Human Differentiated Epidermis and Its Regulation
by Cytokines
Ikuko Numata1, Ryuhei Okuyama1, Ai Memezawa1, Yumiko Ito1, Kazuhisa Takeda2, Kazumichi Furuyama2,
Shigeki Shibahara2 and Setsuya Aiba1
Although heme oxygenase-1 (HO-1) is induced in keratinocytes after UV radiation, HO-1 expression during
normal epidermal differentiation has not yet been reported. We showed by real-time PCR, western blotting, and
ELISA that HO-1 mRNA and protein expression by cultured normal human keratinocytes was upregulated
during epidermal differentiation induced by a high-calcium medium. Immunohistochemical staining and in situ
hybridization showed the graduated expression of HO-1 in the upper epidermis, which was accompanied by
suprabasal HO-1 mRNA expression, and the accumulation of bilirubin (BR) in the stratum corneum. We
examined the activation of nuclear factor E2-related factor 2 (Nrf2), which is a pivotal transcription factor for
HO-1 expression, by western blotting and by examining the mRNA expression of Nrf2 target genes, and
excluded its role in HO-1 expression in epidermal differentiation. Next, we examined the regulation of HO-1
expression by inflammatory cytokines. IL-4 and IL-22 significantly reduced HO-1 mRNA and protein expression,
whereas IL-1b, IL-17A, and tumor necrosis factor-a (TNF-a) increased it. Finally, immunohistochemical studies on
psoriatic lesional skin showed that HO-1 expression was downregulated in the parakeratotic epidermis,
whereas it was retained in the orthokeratotic epidermis. These studies demonstrate that HO-1 is functionally
expressed by keratinocytes in parallel with epidermal differentiation and that its expression is independently
affected by several cytokines.
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INTRODUCTION
Heme oxygenase (HO) catalyzes the first and rate-limiting
step in the oxidative degradation of free heme to produce
equimolar quantities of carbon monoxide, ferrous iron, and
biliverdin (BV) (Tenhunen et al., 1968; Yoshida and Kikuchi,
1978). BV is subsequently converted into bilirubin (BR) by BV
reductase, and iron is recycled for heme synthesis. Two
genetically distinct isoforms of HO have been characterized:
an inducible form, heme oxygenase-1 (HO-1), and a
constitutively expressed form, heme oxygenase-2 (HO-2)
(reviewed by Furuyama et al., 2007).
A number of intracellular signaling molecules and their
downstream transcription factors have been identified as
regulating HO-1 expression (Farombi and Surh, 2006; Alam
and Cook, 2007). Among these intracellular signaling
molecules, the mitogen-activated protein kinases (MAPKs)—
that is, extracellular signal-regulated kinase (ERK), c-Jun NH2-
terminal kinase or stress-activated protein kinase, and
p38MAPK—have been thought to play major roles in
controlling the upregulation of HO-1 (Alam and Cook,
2007). Activation of one or more of these MAPKs by external
stimuli triggers HO-1 gene expression. Other signaling
enzymes that are likely to be implicated in HO-1 induction
include protein kinase C, protein kinase A, and phosphati-
dylinositol 3-kinase (Farombi and Surh, 2006; Alam and
Cook, 2007).
On the other hand, HO-1 is directly regulated by several
transcription factors. The nuclear factor E2-related factor 2
(Nrf2) is well known to be more important in HO-1
expression. Nrf2 has been shown to play an essential role
in the expression of phase II detoxifying, antioxidant, and
stress-inducible genes (Itoh et al., 1997). Under normal
physiological conditions, Nrf2 resides in the cytoplasm
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bound to its inhibitor protein, Keap-1. On stimulation, Nrf2 is
released from Keap-1 and rapidly translocates to the nucleus
(Kobayashi and Yamamoto, 2006). The active Nrf2 binds to
cis-elements having a common core sequence known as the
Maf recognition element or antioxidant-responsive element
(Lee and Surh, 2005), leading to the expression of a battery of
target genes. The important role of Nrf2 in the stress-
dependent expression of HO-1, which is well known to
contain several Maf recognition element sequences, has been
highlighted by the finding that HO-1 is less inducible in Nrf2-
deficient mice (Khor et al., 2006). In addition to Nrf2,
activator protein-1 and NF-kB have been implicated in the
induction of HO-1 expression in response to diverse stimuli,
such as hemin (Shan et al., 2004), sodium arsenite, and
cobalt chloride (Lu et al., 2000).
HO-1 can be induced primarily by its substrate, free heme,
as well as by a wide variety of stimuli, including hypoxia,
hyperoxia, proinflammatory cytokines, nitric oxide, heavy
metals, UV radiation, heat shock, shear stress, and hydrogen
peroxide (Ryter et al., 2006). This adaptive response of HO-1
to these cytotoxic stimuli implies that HO-1, in addition to its
role in heme degradation, may function as a critical
cytoprotective molecule.
In the skin, HO-1 is strongly induced after long-wave UV
radiation (Tyrrell and Reeve, 2006; Black et al., 2008). It
plays a general role in cutaneous wound repair and the
resolution of inflammation (Hanselmann et al., 2001; Pae
et al., 2008a). Interestingly, the overexpression of HO-1 was
reported in psoriatic skin immunohistologically (Hanselmann
et al., 2001).
Despite extensive studies of HO-1 expression and its
biological roles, to our knowledge, HO-1 expression in the
course of normal epidermal keratinization has not yet been
reported. In our study, we first examined HO-1 mRNA and
protein expression by cultured normal human epidermal
keratinocytes (NHEKs) in the course of epidermal differentia-
tion induced by a high-calcium medium. Next, we examined
HO-1 mRNA and protein expression in normal human skin
by immunohistochemistry and in situ hybridization. Finally,
we examined the regulation of HO-1 mRNA and protein
expression by inflammatory cytokines. Because these studies
showed that IL-4 and IL-22 significantly reduced HO-1
expression, whereas IL-1b, IL-17A, and tumor necrosis factor-a
(TNF-a) increased it, we examined HO-1 expression in
psoriasis. These studies demonstrated the expression of HO-1
in parallel with epidermal differentiation and its regulation in
psoriasis by inflammatory cytokines.
RESULTS
HO-1 expression is associated with keratinocyte differentiation
Although previous studies have shown that various stimuli
induce HO-1 expression (Shimizu et al., 2003; Tyrrell and
Reeve, 2006; Black et al., 2008), it is still an open question
whether HO-1 expression is regulated in the course of
normal epidermal differentiation. In this study, we first
examined HO-1 mRNA and protein expression by NHEKs
cultured for 0, 2, 4, and 6 days in a high-calcium medium.
The appropriate induction of differentiation was first
evaluated by profilaggrin and loricrin mRNA expression
(Figure 1a and b). The studies using quantitative real-time
PCR confirmed the augmentation of the expression of both
mRNAs depending on the duration of the culture, suggesting
that the culture in high-calcium medium induced epidermal
differentiation in a time-dependent manner.
Next, we examined HO-1 and HO-2 mRNA expression by
NHEKs. Expression of HO-1 mRNA by keratinocytes was also
significantly augmented in a culture-time-dependent manner,
whereas HO-2 mRNA did not show any significant change
(Figure 1c and d). Consistent with the mRNA expression, both
western blot analysis and ELISA showed that HO-1 protein
was also induced by NHEKs treated with high-calcium
medium in a time-dependent manner (Figure 2a and b).
Again, the expression of HO-2 did not show any significant
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Figure 1. HO-1 expression was associated with epidermal differentiation.
NHEKs were cultured in the presence of 1.5mM calcium. Total RNA was
extracted at the indicated times, and profilaggrin, loricrin, HO-1, and HO-2
mRNA expression was examined by quantitative real-time PCR assay. Data
are presented as mean±SEM of the relative ratio (n¼ 5, *Po0.05, **Po0.01).
(a) Profilaggrin, (b) loricrin, (c) HO-1, and (d) HO-2.
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change throughout the culture period (Figure 2b). These
data indicated that the expression of HO-1 mRNA and
protein by NHEKs is augmented in the course of epidermal
differentiation.
HO-1 is expressed in differentiated keratinocytes in vivo
Next, we examined HO-1 protein and mRNA expression in
normal human skin by immunohistochemistry and in situ
hybridization, respectively. The immunohistochemical stain-
ing of normal skin sections showed the graduated expression
of HO-1 in the upper epidermis, with the most prominent
HO-1 expression in the granular layer (Figure 3b). In contrast,
HO-2 was weakly but ubiquitously expressed in the entire
epidermis (Figure 3c). Neither nonreactive rabbit antibody
(Ab) (Figure 3q) nor anti-HO-1 Ab preincubated with
recombinant rat HO-1 (Figure 3r) produced positive signals.
As the interface between the human body and the outer
environment, the skin is directly exposed to chemical
oxidants, air pollutants, and UV radiation, all of which are
potent inducers of reactive oxygen species and can poten-
tially induce HO-1 (Cooper et al., 2007). Therefore, to
ascertain whether HO-1 expression is induced in the course
of epidermal differentiation or is induced by environmental
factors, we investigated HO-1 expression in epidermal cysts,
which are not directly exposed to UV or other environmental
factors. Even in the epidermal cysts, we could detect the
expression of HO-1 in the differentiated epidermis with the
highest concentration in the granular layer (Figure 3f).
HO catalyzes the degradation of cellular free heme to
produce carbon monoxide, iron, and BV, and BV is
subsequently converted into BR (Tenhunen et al., 1968;
Yoshida and Kikuchi, 1978). Thus, to ascertain whether heme
is in fact degraded by HO reaction in normal epidermis,
we examined the deposits of BR in the epidermis by
immunohistochemistry using anti-BR Ab. Interestingly, BR
accumulated in the stratum corneum (SC) in both normal skin
and epidermal cysts (Figure 3d and h). Mouse isotype control
Ab (Figure 3s) did not produce positive signals. This indicates
the local degradation of heme in the epidermis.
To further confirm HO-1 expression in the differentiated
epidermis, we investigated HO-1 expression in both differ-
entiated and undifferentiated squamous cell carcinomas
(SCCs) and in porokeratosis accompanying cornoid lamella.
HO-1 expression was augmented in cells surrounding horn
pearls in highly differentiated SCCs (Figure 3j), whereas
undifferentiated keratinocytes in SCCs did not show any HO-
1 expression. In correlation with HO-1 expression, BR
accumulated in horn pearls (Figure 3l). On the other hand,
in cornoid lamella of porokeratosis, HO-1 expression in the
upper epidermis accompanying BR accumulation in the
overlying SC was observed only in the orthokeratotic
epidermis, not in the parakeratotic epidermis (Figure 3n and p).
Taken together, these data suggest the functional expression of
HO-1 in the course of normal epidermal differentiation.
To confirm the immunohistochemical studies, we con-
ducted in situ hybridization analysis in normal skin and
epidermal cysts. In these studies, the antisense HO-1 RNA
probe showed positive signals in suprabasal layers, clearly
sparing the basal layer (Figure 4a and c), whereas the sense
RNA probe showed only marginal signals (Figure 4b and d).
These data also indicate that HO-1 is induced in association
with epidermal differentiation.
Nrf2 is not activated in differentiated keratinocytes
Several transcription factors have been reported to regulate
HO-1 expression; among them, Nrf2 is well known to be
particularly important (Pae et al., 2008b). Specifically,
Wakabayashi et al. (2003) have reported that Keap-1-null
mice in which Nrf2 is constitutively activated have notice-
ably thicker SC and express loricrin more abundantly than
their wild-type littermates, suggesting a role of Nrf2 in
epidermal differentiation. Therefore, we assumed that HO-1
expression in the differentiated keratinocytes is also mediated
by Nrf2 and therefore carried out western blot analysis of
Nrf2 protein, because Goven et al. (2008) have recently
shown a tight correlation between the Nrf2 protein level in
the cytosol, as well as in the nucleus, and the expression of
Nrf2 target molecules, HO-1, glutathione peroxidase 2, and
NAD(P)H:quinone oxidoreductase 1, in the lung tissue and
alveolar macrophages in patients with emphysema. How-
ever, we could not find any significant upregulation of Nrf2 in
the differentiated keratinocytes (Supplementary Figure S1a).
We next examined the mRNA expression of two representa-
tive Nrf2 target genes, ferritin heavy chain (MacKenzie
et al., 2008) and NAD(P)H:quinone oxidoreductase 1
(Wakabayashi et al., 2003; Goven et al., 2008), in calcium-
induced keratinocyte differentiation. In agreement with the
western blot data, the mRNA level of neither gene was
upregulated (Supplementary Figure S1b and c). These results
indicate that Nrf2 does not play a role in HO-1 expression in
differentiated keratinocytes.
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Figure 2. HO-1 protein was induced in association with epidermal
differentiation. NHEKs were cultured in the presence of 1.5mM calcium.
Cells were harvested at the indicated time. (a) Concentrations of HO-1 protein
(ng per mg of total cell protein) were determined by ELISA. The values are
expressed as mean±SEM (n¼5, *Po0.05). (b) The presence of HO-1 and
HO-2 was determined by immunoblots using anti-HO-1 and anti-HO-2 Abs.
To verify that cell lysates contained equal concentrations of protein, the
lysates were also probed with anti-b-actin Ab.
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HO-1 regulation by inflammatory cytokines
Several papers have reported that inflammatory cytokines
induce HO-1 in various types of cells (Donnelly and Barnes,
2001; Fernandez et al., 2003; Jung et al., 2004; Kobayashi
et al., 2006), but, to our knowledge, their effects on
epidermal HO-1 expression have not been reported. Re-
cently, it has become clear that some inflammatory cyto-
kines, for example, IL-4, IL-13, and IL-22, modify
keratinocyte differentiation (Boniface et al., 2005; Howell
et al., 2007; Kim et al., 2008). It is therefore conceivable that
they also affect HO-1 induction. When we cultured NHEKs
for 4 days in a high-calcium medium together with various
cytokines, we found that, among the examined cytokines
(IL-1b, IL-4, IL-6, IL-10, IL-13, IL-17A, IL-22, IL-23, TNF-a, and
IFN-g), IL-4, IL-6, IL-13, and IL-22 significantly reduced HO-1
mRNA expression, whereas IL-1b, IL-17A, and TNF-a sig-
nificantly increased it. Other cytokines, such as IL-10, IL-23,
and IFN-g, did not affect HO-1 mRNA expression (Figure 5a).
When we examined HO-2 mRNA expression, IL-4, IL-6,
and IL-22 significantly suppressed HO-2 mRNA expression,
whereas IL-1b, IL-17A, and TNF-a significantly augmented
HO-2 mRNA expression. Again, IL-10, IL-13, IL-23, and IFN-
g did not affect HO-2 mRNA expression (Figure 5b).
Next, to evaluate the correlation between HO-1 mRNA
expression and epidermal differentiation after cytokine
stimulation, we examined the effects of these cytokines on
profilaggrin mRNA expression. Among the examined cyto-
kines, IL-4, IL-6, IL-13, and IL-22 significantly suppressed
profilaggrin mRNA expression. None of the cytokines
augmented profilaggrin mRNA expression (Figure 5c).
When we examined the effects of the cytokines on HO-1
protein expression by ELISA, IL-4 and IL-22 significantly
reduced HO-1 protein expression, whereas IL-1b, IL-17A,
and TNF-a augmented it (Figure 5d).
Downregulation of HO-1 expression in the parakeratotic
epidermis of psoriatic lesional skin
It has been reported that HO-1 and HO-2 are overexpressed
in psoriatic lesional skin (Hanselmann et al., 2001). On the
other hand, accumulating evidence has implicated the
crucial role of T helper 17 (Th17) cells in the pathogenesis
of psoriasis. In particular, in psoriatic lesional skin, IL-23 that
is overproduced by dendritic cells and keratinocytes stimu-
lates Th17 cells in the dermis to make Th17 cytokines
including IL-17A, IL-17F, TNF-a, IL-21, and IL-22 (reviewed
by Blauvelt, 2008). Among these Th17 cytokines, IL-22 has
H&E HO-1 HO-2 BR
Normal
EC
SCC
PK
Figure 3. HO-1 is expressed in terminally differentiated keratinocytes in vivo. Hematoxylin and eosin (a, e, i, and m) and immunohistochemical staining of
HO-1 (b, f, j, and n), HO-2 (c, g, k, and o), and BR (d, h, l, and p) in normal skin (a–d), epidermal cyst (EC) (e–h), SCC (i–l), and porokeratosis (PK) (m–p). Staining
of normal skin using nonreactive rabbit Ab (q), pre-absorbed anti-HO-1 Ab (r), and mouse isotype control Ab (s). Arrowheads indicate positive staining for BR.
Figures show representative images of 15 specimens of normal skin, 8 of epidermal cysts, 6 of SCC, and 5 of porokeratosis. Bar¼100 mm.
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come into prominence in the pathogenesis of psoriasis,
because it is a potent stimulus for keratinocyte proliferation
(Ma et al., 2008).
Interestingly, our study revealed that two representative
Th17 cytokines—IL-17A and IL-22—had opposite effects on
HO-1 and HO-2 expression. Hence, we conducted immuno-
histochemical studies on the expression of HO-1 and HO-2
and BR accumulation in psoriatic lesional skin. In contrast to
a previous report (Hanselmann et al., 2001), the results
showed a rather heterogeneous HO-1 staining pattern,
depending on the specimen and the area. As it is well known
that psoriatic lesions show either orthokeratosis or paraker-
atosis, we examined the correlation between the histological
changes in SC and HO-1 expression. The histological
examination of 21 psoriatic lesional skin specimens indicated
that HO-1 expression was downregulated in the epidermis
showing parakeratosis (Figure 6f), whereas it was substan-
tially retained in the epidermis under orthokeratotic SC
(Figure 6e). To clarify whether HO-1 expression in the
orthokeratotic epidermis in psoriatic lesional skin is either
augmented or downregulated compared with the uninvolved
skin, we focused on HO-1 expression in five specimens of the
skin biopsy containing both perilesional skin and active
psoriatic lesion. The results showed that HO-1 expression in
the orthokeratotic epidermis (Figure 6e) of psoriatic lesion
was comparable with that in the uninvolved skin (Figure 6d).
In contrast to HO-1 expression, HO-2 expression in psoriatic
lesional skin did not significantly differ from that in normal
skin or perilesional skin (Figure 6g–i) and did not change
depending on the keratinization pattern of the SC.
When we stained BR, there was no accumulation of BR in
the parakeratotic SC (Figure 6l), reflecting less HO-1
induction in the underlying layer. On the other hand, BR
accumulation could be detected in the orthokeratotic SC
(Figure 6k) of psoriasis and perilesional skin (Figure 6j).
Furthermore, the in situ hybridization study showed that
HO-1 mRNA was also decreased in the suprabasal layers
under the parakeratotic SC (Supplementary Figure S2a–d).
These data indicate that HO-1 expression is correlated with
the keratinization pattern of the overlying SC.
DISCUSSION
In this study, we have demonstrated in vitro that HO-1 mRNA
and protein expression is closely related to epidermal
differentiation, whereas HO-2 mRNA and protein expression
is rather constant throughout the differentiation process.
Next, using immunohistochemical staining and in situ
hybridization, we have shown that HO-1 expression in
association with epidermal differentiation can be observed
not only in normal human epidermis but also in epidermal
cysts and well-differentiated areas of SCC. In contrast, HO-1
expression was suppressed or undetectable in the abnormal
keratinization of parakeratotic areas of cornoid lamella and
psoriatic lesional skin.
Epidermal gene expression is activated in a precise
temporal and spatial manner during epidermal differentia-
tion-specific genes are activated during early differentiation,
whereas other genes are expressed later. This sequential
activation is functionally important. For example, proteins
such as involucrin, which is involved in the early stages of
differentiation, are expressed in the immediate suprabasal
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Figure 5. Regulation of HO-1 mRNA and protein expression by
inflammatory cytokines. (a–c) NHEKs were cultured for 4 days in the presence
of several cytokines in high-Ca medium. Total RNA was isolated and mRNA
expression was examined by quantitative real-time PCR assay. Data are
plotted as mean±SEM of the relative ratio (n¼ 5–9, *Po0.05, **Po0.01,
***Po0.001). (a) HO-1, (b) HO-2, and (c) profilaggrin. (d) To determine the
effects of cytokines on HO-1 protein expression, NHEKs were cultured for 4
or 5 days in the presence of the cytokines indicated in high-calcium medium.
Concentrations of HO-1 protein (ng per mg of total cell protein) were
determined by ELISA. The values are expressed as mean±SEM of the relative
ratio (n¼ 6–10, *Po0.05, **Po0.01, ***Po0.001).
Antisense Sense
Normal
EC
Figure 4. Epidermal HO-1 mRNA expression in vivo. In situ hybridization of
HO-1 mRNA in normal (a, b) and epidermal cyst (c, d). Antisense (a, c) RNA
probe and sense (b, d) RNA probe. Bar¼ 100mm.
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layers, whereas loricrin, which is utilized late in differentia-
tion, is expressed later (Crish et al., 2002).
Because HO-1 protein showed a graduated expression in
the upper epidermis with the most prominent expression in
the granular layer, HO-1 seemed to be involved in the late
stage of differentiation. Studies of loricrin or profilaggrin gene
expression have already shed light on several key mole-
cules—protein kinase C-a (Papp et al., 2004; Seo et al.,
2004), ERK1/2 and p38MAPK (Seo et al., 2004), activator
protein-1 (Jang et al., 1996; Rossi et al., 1998), and CCAAT/
enhancer binding protein (Wang et al., 2008)—as the genes
that regulate late epidermal differentiation. Recently, it has
been reported that Nrf2, which is one of the pivotal
transcription factors in HO-1 expression, plays a role in
epidermal differentiation (Wakabayashi et al., 2003). There-
fore, we examined whether Nrf2 is activated in the course
of keratinocyte differentiation induced by high-calcium
medium. However, the study of Nrf2 protein expression
using western blotting and of mRNA expression of Nrf2 target
genes using real-time PCR excluded the activation of Nrf2. So
far, the transcription factors responsible for HO-1 expression
in epidermal differentiation remain to be determined.
Next, in this study, we demonstrated significant effects of
inflammatory cytokines on HO-1 expression by keratino-
cytes. Interestingly, the effects of several cytokines on HO-1
mRNA expression by keratinocytes paralleled their effects on
profilaggrin mRNA expression. In particular, IL-4, IL-6, IL-13,
and IL-22 significantly suppressed the expression of HO-1
and profilaggrin mRNA.
It is well known that IL-6 and IL-22 phosphorylate signal
transducer and activator of transcription (STAT) 3 in epidermal
keratinocytes (Boniface et al., 2005; Dreuw et al., 2005).
Moreover, Boniface et al. (2005) have reported that IL-22
downregulates involucrin, loricrin, and profilaggrin in NHEKs,
which is consistent with our data. These data suggest that
STAT3 mediates the suppression of HO-1 mRNA expression
by IL-6 and IL-22 and its protein expression by IL-22.
On the other hand, STAT6 transduces IL-4 and IL-13
signals (Yamasaki et al., 2003), and these Th2 cytokines have
been reported to inhibit profilaggrin mRNA and protein
OrthokeratosisPeri-lesion
H&E
HO-1
HO-2
BR
Parakeratosis
Figure 6. The expression of HO-1 protein in the perilesional skin and the orthokeratotic and parakeratotic epidermis of psoriatic lesional skin.
(a–c) Hematoxylin and eosin, (d–f) HO-1, (g–i) HO-2, and (j–l) BR staining of perilesional (a, d, g, j), orthokeratotic (b, e, h, and k), or parakeratotic (c, f, i, and l)
lesion in the biopsy specimen of a patient with psoriasis. Arrowheads indicate positive staining for BR. Figures show representative images of 21 psoriatic cases,
including 5 cases that contain both perilesional and lesional skin. Bar¼ 100mm.
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expression in primary human keratinocytes (Howell et al.,
2007). Consistent with this report, our study also demon-
strated that both IL-4 and IL-13 significantly suppressed
profilaggrin mRNA expression. In addition, our data showed
that IL-4 significantly suppressed HO-1 mRNA and protein
expression by NHEKs, suggesting the role of STAT6 signaling
in HO-1 expression by keratinocytes.
IL-17 significantly enhanced HO-1 mRNA and protein
expression. It is known that IL-17 binding to its receptors
activates both ERK and p38MAPK in human epidermal
keratinocytes (Kanda et al., 2005). These MAPK cascades
may be involved in the IL-17-induced HO-1 expression,
because Lee et al. (2008) have reported that ERK or p38MAPK
induces HO-1 expression in human keratinocytes. IL-1b and
TNF-a also significantly augmented HO-1 mRNA and protein
expression. It is well known that both cytokines activate JNK,
p38MAPK, and NF-kB (Ninomiya-Tsuji et al., 1999; Baud
and Karin, 2001; Otkjaer et al., 2007). Given that p38MAPK
and NF-kB have been reported to induce HO-1 expression,
the effects of both cytokines might be mediated by these
signaling molecules.
In contrast to previous studies reporting that HO-2 is
constitutively expressed by most cells (Takeda et al., 1994;
Takahashi et al., 1996, 1997), our study showed that HO-2
expression by NHEKs was also regulated by several
cytokines. Moreover, HO-2 mRNA expression was affected
by most of the cytokines in the same manner as HO-1 mRNA
expression. However, the expression of HO-2 in psoriatic
lesional skin was not significantly different from that in
normal skin. Because the effect of cytokines such as IL-22 and
IL-17A on HO-2 mRNA expression was smaller than their
effect on HO-1 mRNA expression, their effect on HO-2
protein expression might be marginal. Further study is clearly
required with regard to the cytokine regulation of HO-2
expression in keratinocytes.
Hanselmann et al. (2001) reported the overexpression of
HO-1 in psoriatic skin. In contrast, our study showed that
HO-1 expression was altered depending on the keratinization
pattern in the overlying SC. Recently, Lowes et al. (2008)
reported that psoriatic lesions contain Th1 and Th17 cells,
showing the augmented expression of IFN-g, IL-17, and
IL-22. In our study, it became clear that these three cytokines
regulate HO-1 expression differently. Therefore, it is reason-
able that HO-1 expression in psoriatic lesional skin showed a
rather heterogeneous staining pattern. Indeed, human leuko-
cyte antigen (HLA)-DR expression by keratinocytes, which is
well known to be induced by IFN-g, did not show diffuse
staining in psoriatic lesional skin (Gottlieb et al., 1986). Our
study and the study on HLA-DR expression, in addition to the
combination of orthokeratosis and parakeratosis in psoriatic
lesional skin, suggest that the distribution of Th1 and Th17
may be spatially heterogeneous.
SC is composed of protein-enriched and lipid-depleted
corneocytes (‘‘bricks’’) surrounded by an intercellular domain
(‘‘mortar’’) consisting of hydrophobic, lipid-enriched mem-
brane bilayers. Previous studies have demonstrated that SC
lipids and proteins are targets of oxidative stress (Thiele et al.,
1997, 1999). To protect against oxidative damage, the skin is
equipped with a large network of enzymatic antioxidant
defense systems, such as catalase, superoxide dismutase,
and glutathione peroxidase, as well as nonenzymatic
antioxidants, such as vitamin E, ascorbate, glutathione, and
uric acid, which work in synergy to counterbalance oxidative
stress (reviewed by Hellemans et al., 2003). Among them,
a-tocopherol, ascorbate, and urate are considered the
major antioxidants in the SC (Thiele, 2001). However,
Stocker et al. (1987) have reported that BR efficiently
scavenges peroxyl radicals, suppresses oxidation more
than a-tocopherol, and can function as the best antioxidant
of lipid peroxidation. Now that we have clearly demons-
trated in our study that SC contains a substantial amount of
BR, it is time to reconsider the role of BR in the SC as an
antioxidant.
Finally, HO catalyzes free heme into equimolar quantities
of carbon monoxide, ferrous iron, and BV. Therefore, our
study showing HO-1 expression in the upper epidermis with
the most prominent expression in the granular layer and a
close correlation between BR in the SC and HO-1 expression
in the underlying epidermis indicates that free ferrous iron is
produced in the upper epidermis. Interestingly, on the
basis of observation of a human skin specimen using
proton-induced X-ray emission analysis, Forslind et al.
(1999) reported that iron has its peak value in the basal
region and declines toward the SC in normal human
epidermis. Therefore, it is assumed that free ferrous iron
produced by HO-1 is excreted outside the differentiated
keratinocytes. Recently, it has been shown that several factors,
such as hepcidin, ferritin, and ferroportin, determine the fate of
iron inside cells (Dunn et al., 2007). To further clarify the fate
of iron in differentiated keratinocytes, it is clearly necessary to
investigate the expression of these factors.
MATERIALS AND METHODS
Reagents
We used the following cytokines: recombinant human IL-1b, IL-4,
IL-6, IL-10, IL-13, IL-17A, TNF-a, and IFN-g were purchased from
PeproTech (London, UK), and recombinant human IL-22 and IL-23
were purchased from R&D Systems (Minneapolis, MN). The Abs we
used were rabbit Ab against HO-1 (SPA-896), HO-2 (OSA-200)
(Stressgen, Ann Arbor, MI), and Nrf2 (C-20) (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) and mouse monoclonal Ab against BR
(24G7) (Dojindo, Tokyo, Japan), horseradish peroxidase (HRP)-
conjugated goat anti-mouse Ab (Santa Cruz Biotechnology), biotin-
conjugated goat anti-rabbit IgG Ab (Cell Signaling Technology,
Danvers, MA), and HRP-conjugated goat anti-biotin Ab
(Cell Signaling Technology).
Tissue samples
After obtaining ethical approval and informed consent, and in
compliance with the Declaration of Helsinki Principles, we
collected archival formalin-fixed paraffin-embedded specimens from
21 patients with psoriasis vulgaris, 8 with epidermal cysts, 6 with
SCC, and 5 with porokeratosis and 15 normal skin specimens from
the Department of Dermatology, Tohoku University Graduate
School of Medicine. We used the uninvolved region surrounding
benign skin tumors as normal skin.
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Immunohistochemistry
Formalin-fixed paraffin-embedded tissue samples were sectioned at
4–6 mm thickness and deparaffinized. These sections were incubated
in 0.3% hydrogen peroxide for 15minutes at room temperature to
quench endogenous peroxidase activity, further blocked with goat
serum for 10minutes, and then exposed to primary Ab, rabbit anti-
HO-1 polyclonal Ab (1:1,000 dilution), rabbit anti-HO-2 polyclonal
Ab (1:500 dilution), nonreactive rabbit Ab (1:500 dilution), mouse
monoclonal anti-BR Ab (5mgml1), or mouse isotype control Ab
(5mgml1) at 4 1C overnight. Ab binding was shown via peroxidase-
conjugated anti-rabbit immunoglobulin (Histofine MAX-PO (R) kit;
Nichirei, Tokyo, Japan) for anti-HO-1 or anti-HO-2 Ab, or via
peroxidase-conjugated anti-mouse immunoglobulin kits for anti-BR
Ab (Histofine MAX-PO (M) kit, Nichirei). In some experiments, anti-
HO-1 Ab was preincubated with recombinant rat HO-1 (Stressgen).
Finally, the sections were visualized with 3,3-diaminobenzidine
tetrahydrochloride (Wako Pure Chemical Industries, Osaka, Japan).
In the staining for anti-BR Ab, we conducted autoclave unmasking
(5minutes at 121 1C in 10mmol l1 citrate buffer, pH 6.0).
Keratinocyte culture and treatment with cytokines
NHEKs (KURABO, Osaka, Japan) were cultured in a serum-free
keratinocyte growth medium (HuMedia-KG2) (KURABO) containing
0.15mM calcium, EGF (0.1 ngml1), bovine pituitary extract (0.4%
(vol/vol)), insulin (10mgml1), and hydrocortisone (0.5 mgml1) at
37 1C under 5% carbon dioxide–95% air. The cultures were passaged
by trypsinization and studied in passage 2. The medium was
replaced every 2 days. The cultures were maintained in low-calcium
medium (0.15mM) until approximately 80–90% confluence was
reached. The induction of keratinocyte differentiation was achieved
by culturing the cells in the presence of 1.5mM calcium in the
culture medium as previously described (Stanley and Yuspa, 1983).
In the experiments to examine the effects of cytokines on HO-1
induction by keratinocytes, the keratinocytes were cultured in
HuMedia-KG2 medium containing 1.5mM calcium supplemented
with IL-1b (100 ngml1), IL-4 (100 ngml1), IL-6 (100 ngml1), IL-10
(100 ngml1), IL-13 (100 ngml1), IL-17A (100 ngml1), IL-22
(100 ngml1), IL-23 (100 ngml1), TNF-a (100 ngml1), or IFN-g
(25 ngml1).
Real-time PCR analysis
Total RNA was extracted using the guanidinium thiocyanate method
described by the manufacturer (Isogen, Nippon Gene, Toyama,
Japan) from NHEKs. cDNA was obtained from total RNA using a
TaKaRa RNA PCR kit (AMV) (Takara Biochemicals, Osaka, Japan)
according to the manufacturer’s protocol. Quantitative, fluorescent
PCR was carried out using the TaqMan system (ABI7700; Applied
Biosystems, Foster City, CA). Sequences for human ribosomal
protein large P0 (RPLP0), HO-1, HO-2, NAD(P)H:quinone oxidor-
eductase 1, and ferritin heavy chain were obtained from GenBank.
Forward and reverse primers and TaqMan probes were prepared by
SIGMA GENOSYS (Hokkaido, Japan). The primers and probes used
in these studies are listed in Supplementary Tables S1 and S2.
Primers and probes used for profilaggrin and loricrin were obtained
from TaqMan Gene Expression Assays (Applied Biosystems). PCRs
were performed in triplicate in 30-ml total reaction volumes with
66 nM TaqMan probe, 400 nM forward primers, 400 nM reverse
primers, and 2 QuantiTect Probe PCR (Qiagen, Dusseldorf,
Germany). Thermal cycling was carried out for 2minutes at 50 1C
to deplete any contaminating RNA and 10minutes for denaturation
at 95 1C, followed by 40 cycles at 95 1C for 15 seconds and 60 1C for
1minute in an ABI Prism 7700 detection system (Applied
Biosystems). The levels of cDNA were calculated using standard
curves generated with bona fide human cDNAs in which there was a
linear relationship between the number of cycles required to exceed
the threshold and the number of copies of cDNA added. The relative
ratio was calculated by dividing the copy number of cDNA for each
gene by that of cDNA for RPLP0. In this study, we decided to use
RPLP0 as the endogenous control by using a commercially available
TaqMan human endogenous control plate (Applied Biosystems),
which included 11 candidate controls (data not shown).
ELISA
HO-1 concentrations in cell lysates were quantified using the HO-1-
specific ELISA kit (Stressgen) according to the manufacturer’s
instructions. The results were normalized with respect to the
concentrations of cell lysate protein determined using a BCA protein
assay (Pierce, Rockford, IL).
Protein extraction and western blotting
The keratinocytes were cultured for 0, 2, 4, and 6 days in HuMedia-
KG2 medium in the presence of 1.5mM calcium. The cells were
washed with phosphate-buffered saline and resuspended in cell
lysis buffer (Cell Signaling Technology, Beverly, MA). They were
collected into Eppendorf tubes and then sonicated and centrifuged at
12,000 g for 5minutes at 4 1C. The supernatants that contained cell
proteins were stored at 80 1C until use. Aliquots of the protein were
electrophoresed and transferred onto nitrocellulose membranes.
Electroblotted membranes were blocked with TBST (50mM Tris (pH
7.5) and 0.5% Tween) containing 5% nonfat dried milk; incubated
with rabbit anti-HO-1 polyclonal Ab (1:2,000 dilution), rabbit
anti-HO-2 polyclonal Ab (1:5,000 dilution), rabbit anti-Nrf2 Ab
(1:400 dilution), or mouse anti-actin Ab (1:5,000 dilution) overnight
at 4 1C; rinsed with TBST; and incubated with biotinylated anti-rabbit
Ab (1:1,000 dilution) and HRP-conjugated anti-biotin Ab (1:1,000
dilution) or HRP-conjugated anti-mouse Ab (1:1,000 dilution). After
additional rinses with TBST, the blots were exposed to the LumiGLO
reagent (Cell Signaling Technology) and then visualized using LAS-
1000 (Fujifilm, Tokyo, Japan) according to the manufacturer’s
instructions. Equal loading was achieved by normalization of the
protein concentration using a BCA protein assay (Pierce).
In situ hybridization
In situ hybridization was performed using a Ventana HX system
(Ventana Medical Systems, Tucson, AZ). HO-1 mRNA was amplified
by PCR using an Expand High Fidelity PCR system (Roche
Diagnostics, Tokyo, Japan) in a 50 ml reaction mixture. Forward
and reverse primers were made by SIGMA GENOSYS. The
sequences of primers are shown in Supplementary Table S3.
Amplification was performed as follows: 2minutes at 94 1C for
initial denaturation and 30 cycles of 94 1C denaturing for 15 s, 60 1C
annealing for 30 s, and 72 1C extension for 30 seconds, followed by a
final extension at 72 1C for 7minutes. Quality and quantity of the
purified PCR product were confirmed by 1.2% agarose gel
electrophoresis. Antisense and sense RNA probes were labeled
using the T7/T3 digoxigenin (DIG) RNA labeling kit
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(Roche Diagnostics) according to the manufacturer’s instructions.
The sections were pretreated and hybridized using a Ventana
RiboMap kit (Ventana Medical Systems) on the automated Ventana
HX System Discovery. The sections were hybridized for 3 h at 65 1C
with DIG-labeled RNA probes and incubated with anti-DIG-HRP
(Dako Cytomation, Glostrup, Denmark) for 30minutes at 37 1C, after
which the signals were amplified using a biotinylated tyramide
(AmpMap kit; Ventana Japan KK; Yokohama, Japan) following the
manufacturer’s instructions. Finally, signals were detected by a
BlueMap NBT/BCIP substrate kit (Ventana Japan KK) for 6 h at 37 1C
and counterstained with Nuclear Fast Red (Ventana Japan KK). The
sections were then dehydrated through an ethanol series (80, 90, and
100% ethanol, for 1minute each) and washed for 1minute in xylene
before being mounted in Eukitt mounting medium (O Kindler,
Freiburg, Germany).
Statistics
The Friedman test with the Scheffe post-hoc test and the paired t-test
were used to evaluate the statistical significance of the results.
P-values of o0.05 were considered statistically significant.
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